Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1482 Articles

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Aug 5, 2009 at 9:55 AM EDT

MannKind Raises Over $50 Million (MNKD, PFE)

MannKind Corporation (NASDAQ: MNKD) is getting hit after the company announced that it priced a secondary offering of 7,400,000 shares…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jul 20, 2009 at 11:39 AM EDT

Earnings Previews for 11 of 30 DJIA Components This Week (CAT, DD, MRK, KO, PFE, BA, MMM, AXP, T, MCD, MSFT, MO)

This week will mark the first crest of earnings season as we have 11 of the 30 DJIA components reporting…

Douglas A. McIntyre | Jul 13, 2009 at 10:25 AM EDT

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed…

Douglas A. McIntyre | Jul 11, 2009 at 5:24 AM EDT

Short Sellers Target Big Financial Names (BAC)(AIG)(WFC)(FRE)

Short sellers upped their investments in stocks of the most prominent financial firms. Short interest in Bank of America (BAC),…

Douglas A. McIntyre | Jul 2, 2009 at 4:59 AM EDT

Anti-Smoking Drugs Could Cause Suicide (PFE)(GSK)

It is hard to say whether a person is better off stopping smoking and lessening their chances of a heart…

Douglas A. McIntyre | Jul 2, 2009 at 3:04 AM EDT

Media Digest 7/2/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: California declared a financial emergency. Reuters: An SEC attorney raised concern about a Madoff report in 2004. Reuters: Auto…

Douglas A. McIntyre | Jun 25, 2009 at 11:31 AM EDT

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early…

Douglas A. McIntyre | Jun 22, 2009 at 12:21 PM EDT

Medicare Winners Under New Healthcare Plans (MRK, PFE, AET, CI, CVH, HUM, UNH, WLP)

Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program…

Douglas A. McIntyre | Jun 15, 2009 at 3:01 AM EDT

Media Digest 6/15/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: The heads of the emerging markets, the so-called BRICs, held their first global summit. Reuters: Obama will be tested…

Douglas A. McIntyre | May 27, 2009 at 1:34 PM EDT

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data…

Douglas A. McIntyre | May 14, 2009 at 4:56 PM EDT

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year’s American Society…

Douglas A. McIntyre | Apr 26, 2009 at 1:12 PM EDT

The Top Ten Stocks For Short Sellers (MSFT)(INTC)(SIRI)(F)(AIG)(C)

Short selling is among the most controversial investment practices and has been blamed for sharp sell-offs in the stocks of a number…

Douglas A. McIntyre | Apr 17, 2009 at 2:05 PM EDT

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association…

1 … 88 89 90 91 92 … 99

Pfizer : PFE

All Pfizer Articles

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

MannKind Raises Over $50 Million (MNKD, PFE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Earnings Previews for 11 of 30 DJIA Components This Week (CAT, DD, MRK, KO, PFE, BA, MMM, AXP, T, MCD, MSFT, MO)

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Short Sellers Target Big Financial Names (BAC)(AIG)(WFC)(FRE)

Anti-Smoking Drugs Could Cause Suicide (PFE)(GSK)

Media Digest 7/2/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Medicare Winners Under New Healthcare Plans (MRK, PFE, AET, CI, CVH, HUM, UNH, WLP)

Media Digest 6/15/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

The Top Ten Stocks For Short Sellers (MSFT)(INTC)(SIRI)(F)(AIG)(C)

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

MannKind Raises Over $50 Million (MNKD, PFE)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Earnings Previews for 11 of 30 DJIA Components This Week (CAT, DD, MRK, KO, PFE, BA, MMM, AXP, T, MCD, MSFT, MO)

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Short Sellers Target Big Financial Names (BAC)(AIG)(WFC)(FRE)

Anti-Smoking Drugs Could Cause Suicide (PFE)(GSK)

Media Digest 7/2/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Generic Biotech Drug Approval in Japan, Implications in U.S. and Abroad (NVS, PFE, AZN, AMGN, GENZ, GILD, CELG)

Medicare Winners Under New Healthcare Plans (MRK, PFE, AET, CI, CVH, HUM, UNH, WLP)

Media Digest 6/15/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

The Top Ten Stocks For Short Sellers (MSFT)(INTC)(SIRI)(F)(AIG)(C)

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later